Porter JB - Search Results

1

Secondary erythrocytosis due to compound homozygosity, but not compound heterozygosity, for Hb Luton and α-thalassemia: a family study.

El-Sharkawi D, Fisher C, Khambadkone S, Stephens AD, Porter JB. El-Sharkawi D, et al. Among authors: porter jb. Hemoglobin. 2012;36(1):7-17. doi: 10.3109/03630269.2011.641134. Epub 2012 Jan 4. Hemoglobin. 2012. PMID: 22217338

2

Symptomatic Erythrocytosis Due to Homozygosity for Hb Luton [HBA2: c.269A>T (or HBA1)] and α-Thalassemia: A Clinical Update.

Oliveira A, Warcel D, Huntley N, Eleftheriou P, Porter JB. Oliveira A, et al. Among authors: porter jb. Hemoglobin. 2016;40(2):127-9. doi: 10.3109/03630269.2015.1136935. Epub 2016 Feb 6. Hemoglobin. 2016. PMID: 26852627

3

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.

Jones E, Pasricha SR, Allen A, Evans P, Fisher CA, Wray K, Premawardhena A, Bandara D, Perera A, Webster C, Sturges P, Olivieri NF, St Pierre T, Armitage AE, Porter JB, Weatherall DJ, Drakesmith H. Jones E, et al. Among authors: porter jb. Blood. 2015 Jan 29;125(5):873-80. doi: 10.1182/blood-2014-10-606491. Epub 2014 Dec 17. Blood. 2015. PMID: 25519750 Free PMC article.

4

Psychological Factors Associated with Episodic Chelation Adherence in Thalassemia.

Vosper J, Evangeli M, Porter JB, Shah F. Vosper J, et al. Among authors: porter jb. Hemoglobin. 2018 Jan;42(1):30-36. doi: 10.1080/03630269.2018.1433686. Epub 2018 Mar 9. Hemoglobin. 2018. PMID: 29521137

5

Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.

Porter JB. Porter JB. Hemoglobin. 2009;33 Suppl 1:S37-45. doi: 10.3109/03630260903346627. Hemoglobin. 2009. PMID: 20001631 Review.

6

Which psychosocial factors are related to chelation adherence in thalassemia? A systematic review.

Evangeli M, Mughal K, Porter JB. Evangeli M, et al. Among authors: porter jb. Hemoglobin. 2010 Jun;34(3):305-21. doi: 10.3109/03630269.2010.485080. Hemoglobin. 2010. PMID: 20524820 Review.

7

Selection of hydroxypyridin-4-ones for the treatment of iron overload using in vitro and in vivo models.

Huehns ER, Porter JB, Hider RC. Huehns ER, et al. Among authors: porter jb. Hemoglobin. 1988;12(5-6):593-600. doi: 10.3109/03630268808991649. Hemoglobin. 1988. PMID: 3209401

8

Deferasirox: an update.

Porter JB. Porter JB. Hemoglobin. 2009;33 Suppl 1:S70-5. doi: 10.3109/03630260903347146. Hemoglobin. 2009. PMID: 20001635 Review.

9

Relationship between the severity of beta-thalassaemia syndromes and the number of alleviating mutations.

Ratip S, Petrou M, Old JM, Wonke B, Porter JB, Modell B. Ratip S, et al. Among authors: porter jb. Eur J Haematol. 1997 Jan;58(1):14-21. doi: 10.1111/j.1600-0609.1997.tb01404.x. Eur J Haematol. 1997. PMID: 9020368

10

Why are hemoglobin F levels increased in HbE/beta thalassemia?

Rees DC, Porter JB, Clegg JB, Weatherall DJ. Rees DC, et al. Among authors: porter jb. Blood. 1999 Nov 1;94(9):3199-204. Blood. 1999. PMID: 10556208 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters